Showing results (381-390 of 391) with videos related to
Sort By:
Pageof 40
Oncogene|July 29, 2014
Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinomaY M Yang, W H Lee, C G Lee, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
A humanized anti--4-1BB monoclonal antibody suppresses antigen-induced humoral immune response in nonhuman primatesH J Hong, J W Lee, S S Park, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 24, 2014
Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancerJ-H Ko, K R Peck, W J Lee, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 29, 2016
Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibitionS T Kim, S Y Kim, S J Klempner, et al.Oncogene|April 21, 2001
Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphomaS H Lee, M S Shin, H S Kim, et al.American Journal of Infection Control|December 15, 2000
Multicenter surveillance study for nosocomial infections in major hospitals in Korea. Nosocomial Infection Surveillance Committee of the Korean Society for Nosocomial Infection ControlJ M Kim, E S Park, J S Jeong, et al.Oncogene|February 9, 2016
Novel strategy for a bispecific antibody: induction of dual target internalization and degradationJ M Lee, S H Lee, J-W Hwang, et al.Cancer Research|September 10, 1998
Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancerS M Dong, K M Kim, S Y Kim, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2020
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆S H Park, D H Lim, T S Sohn, et al.Leukemia|January 1, 1996
Chemotherapy versus transplants for acute myelogenous leukemia in second remissionR P Gale, M M Horowitz, J K Rees, et al.Pageof 40